Galapagos named former Horizon Therapeutics exec Aaron Cox as CFO. Saatchi & Saatchi Wellness, a 2025 MM+M Agency 100 honoree, named Brendan Gallagher as president, Beth Bour as chief client officer ...

Dr Dolsten has VC experience from work with Orbimed, ATP and Pfizer venture groups. He has in his Pharma career been involved in numerous small and large corporate transactions exceeding $100B in ...

Mikael Dolsten, retired Chief Scientific Officer and head of Pfizer's Research & Development division, owns 174,395 shares as of the company's 2024 proxy statement.

Mikael Dolsten, who retired from Pfizer late last year, joined Blackstone Life Sciences as a senior adviser in March. The division, which has some $12 billion in assets under management, ...

Before joining Pfizer in 2009, Dolsten held senior leadership roles at Wyeth, Boehringer Ingelheim, and AstraZeneca, where he played a pivotal role in drug discovery across multiple therapeutic areas.

Pfizer said it saw “encouraging” data from an ongoing early stage trial of its oral weight loss drug, danuglipron. Newsletters Games Share a News Tip. ... Mikael Dolsten. ...

Pfizer’s chief scientific officer, Mikael Dolsten, is slated to depart after 15 years at the drug giant. Dolsten will remain in the role while a successor is identified, which Pfizer says could ...

London: Pfizer said on Tuesday Chief Scientific Officer Mikael Dolsten, a key figure behind the development of its COVID-19 vaccine, would step down after a more than 15-year career at the ...

US pharmaceutical giant Pfizer on Tuesday said its chief scientific officer Mikael Dolsten, a key figure behind the development of the company's Covid-19 vaccine, would step down. Dolsten will be ...

Mikael Dolsten’s plans to leave Pfizer, after 15 years helming its research and development, leaves a big hole at the drugmaker as it counts on its pipeline to furnish new sources of sales growth.

Pfizer, Inc. PFE announced it is starting the process to find a new chief scientific officer and president of Pfizer Research and Development. The Details: Mikael Dolsten, the current Chief ...